Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Sandoz Riociguat

Exceptional medication
  • Active ingredient(s):
    riociguat
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Tablet 0.5 mg DIN : 2533545
    • Tablet 1.5 mg DIN : 2533588
    • Tablet 1 mg DIN : 2533561
    • Tablet 2.5 mg DIN : 2533618
    • Tablet 2 mg DIN : 2533596

Qinlock

Exceptional medication
  • Active ingredient(s):
    ripretinib
  • Manufactured by:
    Medison Pharma Canada Inc. (Medison)
  • Strength and dosage form:
    Tablet 50 mg DIN : 2500833

Skyrizi

Exceptional medication
  • Active ingredient(s):
    risankizumab (Crohn's disease)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 60 mg/mL (10 mL) DIN : 2532107
    • S.C. Injectable Solution (mini-doser) 150 mg/mL (2,4 mL) DIN : 2532093

Skyrizi (syringe)

Exceptional medication
  • Active ingredient(s):
    risankizumab (plaque psoriasis)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 150 mg/mL (1 mL) DIN : 2519283

Skyrizi (pen)

Exceptional medication
  • Active ingredient(s):
    risankizumab (plaque psoriasis)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 150 mg/mL (1 mL) DIN : 2519291

Skyrizi

Exceptional medication
  • Active ingredient(s):
    risankizumab (plaque psoriasis)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Subcutaneous Injectable Solution syringe 90 mg/mL (0.83 mL) DIN : 2487454

Evrysdi

Exceptional medication
  • Active ingredient(s):
    risdiplam
  • Manufactured by:
    Hoffmann-La Roche Ltée (Roche)
  • Strength and dosage form:
    Oral Powder 60 mg (0,75 mg/mL) DIN : 2514931

Teva-Risedronate

Covered
  • Active ingredient(s):
    risedronate sodium
  • Manufactured by:
    Teva Canada Ltée (Teva Can)
  • Strength and dosage form:
    • Tablet 30 mg DIN : 2298384
    • Tablet 35 mg DIN : 2298392
    • Tablet 5 mg DIN : 2298376

Actonel

Covered
  • Active ingredient(s):
    risedronate sodium
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Tablet 35 mg DIN : 2246896

Apo-Risedronate

Covered
  • Active ingredient(s):
    risedronate sodium
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    Tablet 35 mg DIN : 2353687
Page 378 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.